I'll cut straight to it. I rate the iShares Core S&P Small-Cap ETF (IJR) a Buy.

The small-cap rotation that strategists have been calling for since mid-2024 has finally arrived with force, and the data supporting it is a fundamental shift in the earnings growth trajectory of smaller companies relative to the mega-caps that have dominated for three straight years. But buying the iShares Russell 2000 ETF (IWM) is the lazy way to play this trade. And lazy, in this case, costs you returns.

My thesis rests on three pillars. First, the quality filter embedded in the S&P SmallCap 600 Index eliminates the roughly 43% of Russell 2000 companies that are unprofitable - dead weight that drags on returns during exactly the kind of sustained rotation we're entering. Second, the ISM Manufacturing PMI's explosive move to 52.6 in January, its first expansion reading in a full year, confirms that this rotation has fundamental backing, not just speculative momentum. And third, the valuation gap between small and large caps has reached levels we haven't seen since the aftermath of the dot-com bubble, and the earnings growth projections for 2026 suggest that gap is going to close.

Approximately 43% of the companies in the Russell 2000 Index produced negative net income per share in their most recent fiscal year. Nearly half the index is losing money. When you buy IWM, you're buying a basket where almost half the holdings are burning cash.

The S&P SmallCap 600, which IJR tracks, applies a profitability screen that the Russell 2000 does not. To be included in the S&P 600, a company must demonstrate positive earnings in its most recent quarter and over the trailing four quarters combined. It's basic quality control, and the difference in outcomes is meaningful.

IJR currently trades at a P/E ratio of approximately 18.2x, compared to the IWM's stated P/E of roughly 72.7x. That IWM figure is wildly distorted by the inclusion of companies with minimal or negative earnings. Strip those out, which is effectively what the S&P 600 does, and you get a much cleaner picture of small-cap valuation.

There's a cost advantage too. IJR charges 0.06% in annual expenses. IWM charges 0.19%. That's more than three times the cost for, in my assessment, an inferior product. Over a five-year holding period on a $100,000 investment, that difference compounds to roughly $650 in fee savings alone. Not life-changing, but it's money that stays in your pocket instead of BlackRock's.

To be fair, IWM has its uses. It's more liquid, it has deeper options markets, and during speculative rallies, those unprofitable companies can rip higher because they're essentially lottery tickets. The micro-cap IWC ETF was up 9.3% in the first three weeks of January for exactly this reason. But I'm not interested in lottery tickets when I'm positioning for a multi-quarter rotation. I want companies that actually make money.

Here's what changed the game for me. On February 2, the ISM reported that the Manufacturing PMI surged to 52.6 in January 2026, up a massive 4.7 percentage points from December's 47.9 reading. That's the first time manufacturing has been in expansion territory in twelve months. And the sub-components were even more impressive.

New Orders hit 57.1 - the highest since February 2022 and nearly 10 points above December's reading. Production expanded to 55.9. Customer inventories dropped to 38.7, deep in "too low" territory, which historically signals that restocking orders are coming. Five of the six largest manufacturing industries reported growth in January.

Why does this matter so much for small caps specifically?

Because the Russell 2000 and the S&P 600 are overwhelmingly domestic. Roughly 77% of Russell 2000 revenue comes from within the United States, compared to about 40% for the S&P 500. When U.S. manufacturing expands, small caps feel it directly. When U.S. manufacturers place new orders at the fastest rate in nearly four years, small-cap industrials, specialty manufacturers, and the regional banks that lend to them all benefit disproportionately.

The ISM Services PMI also came in at 53.8 for January, marking the 19th consecutive month of expansion. Business Activity hit 57.4, the strongest since October 2024. The U.S. economy is broadening out. And broadening is exactly the environment where small caps thrive.

This is the piece that separates a momentum trade from a fundamentally supported rotation. When I see the ISM Manufacturing Index breaking out after 26 straight months of contraction (dating back to late 2023), and I see new orders at multi-year highs, I'm not chasing a hot chart pattern. I'm positioning for an earnings cycle that's just getting started.

Goldman Sachs analyst Ben Snider noted in a December 2025 research note that "dispersion within the Russell 2000 index indicates particularly fertile ground for alpha generation," adding that changes in fiscal policy, rising corporate AI adoption, and increased M&A activity are expected to create "large idiosyncratic returns" for small-cap investors in 2026. That's a clinical way of saying there's money to be made if you pick the right vehicle. Goldman's baseline forecasts roughly 10% returns for the small-cap index over the next twelve months. I think that's conservative, particularly for the quality segment of small caps.

Let me walk through the math because this is where the case gets genuinely compelling.

The S&P SmallCap 600 currently trades at approximately 15.6 times forward earnings estimates. The S&P 500 trades at 22.6 times. That's a 31% discount, and it's considerably wider than the historical average spread. There have been very few periods over the past 25 years where small caps were this cheap relative to large caps, the most notable being the early 2000s, right after the tech bubble popped. Investors who bought small caps at that valuation gap went on to enjoy years of outperformance.

Now layer in the earnings growth projections. Consensus estimates project S&P SmallCap 600 earnings growth of approximately 21% in 2026. Large-cap S&P 500 earnings are expected to grow around 14-15%. The Magnificent Seven's earnings growth is projected at roughly 18%, down from the hyper-growth rates of 2023-2024. For the first time in this cycle, small-cap earnings growth is expected to meaningfully outpace large-cap growth.

Here's a simple framework.

If IJR trades at 15.6x forward earnings today and we see even modest multiple expansion to 17x (still well below the S&P 500's multiple and roughly in line with small caps' long-term average), combined with 21% earnings growth, that gets you to approximately $58-62 per share within 12 months from its current price near $48. That's 20-29% upside.

Compare that to the S&P 500, where you're starting at 22.6x earnings with 14% growth, the upside math simply isn't as attractive unless you're expecting continued multiple expansion in mega-caps, which I'm skeptical about at these levels.

My bear case valuation:

If the economic expansion falters and small-cap earnings growth comes in at 10% instead of 21%, with no multiple expansion, IJR trades roughly flat from here, call it $48-50. That's not great, but it's not a disaster either. The downside is significantly cushioned by the starting valuation. When you're already at 15.6x earnings, there's simply less room to fall than when you're at 22x or 25x.

The risk-reward, as I see it is roughly 20-29% upside in the base case versus 0-5% downside in the bear case. That's a 4:1 to 6:1 ratio. In my experience, those setups are favorable.

I want to take a step back and explain why this rotation is happening now, because understanding the mechanics and where we are in the cycle helps you assess whether it has staying power.

Three structural forces are converging.

The first is interest rates. The Federal Reserve cut rates three times in late 2025, bringing the fed funds rate down to 3.50-3.75%. Small-cap companies are substantially more sensitive to rate changes than large caps because roughly 50% of small-cap debt is floating rate, versus predominantly fixed-rate debt at larger companies. Every 25-basis-point cut translates directly into lower interest expense for these businesses. The rate cuts we've already gotten have meaningfully improved small-cap profitability, and the potential for additional cuts in later 2026, particularly if the Fed gets a new chairman in May who's more sympathetic to easing, could extend this tailwind.

The second force is the reshoring and industrial policy boom. The "One Big Beautiful Bill Act" signed in mid-2025 expanded tax benefits for small businesses and accelerated domestic manufacturing incentives. The ISM's January data is the first concrete evidence that these policies are translating into actual orders and production. Small-cap industrials and specialty manufacturers are the direct beneficiaries here, they're the ones building the factories, supplying the components, and staffing the facilities.

The third, and perhaps most underappreciated, is what I'd call "AI democratization." The initial phase of the AI cycle overwhelmingly benefited the infrastructure providers like Nvidia, the hyperscalers, the data center REITs. But we're now entering a phase where the productivity gains from AI flow to the users of the technology, not just the builders. Small and mid-sized companies adopting AI tools to improve efficiency, reduce costs, and accelerate product development are starting to see margin expansion that wasn't in anyone's models 18 months ago. This shows up in earnings, and the 21% projected growth rate for the S&P 600 reflects it.

I'd be doing a disservice if I didn't lay out the genuine risks here, because small-cap investing always comes with higher volatility and there are real scenarios where this thesis breaks.

Inflation re-acceleration. This is the big one. The ISM's Prices Index registered 59.0 in January, which is elevated. Several survey respondents mentioned buying ahead of expected tariff-related price increases. If inflation ticks back up—say core PCE moves above 3.0% sustainably—the Fed pauses or even reverses its easing cycle. That would be directly negative for rate-sensitive small caps. I'd note that the ISM Services Prices Index came in even hotter at 66.6, which is something I'm watching closely.

The "zombie company" refinancing wall. Even with IJR's profitability filter, some companies in the S&P 600 have significant debt maturing in 2026-2027 that was issued during the ultra-low rate era of 2020-2021. Refinancing that debt at current rates could pressure margins for leveraged names within the index. This risk is substantially lower in IJR than in IWM because of the profitability screen, but it's not zero.

Tariff uncertainty. The Trump administration's evolving tariff policies remain a wildcard. About 40% of ISM survey respondents in January cited tariff concerns. Small domestic manufacturers might benefit from protectionist policies, or they might get caught in the crossfire of retaliatory measures and supply chain disruption. The policy environment is genuinely unpredictable here.

The rotation could be a head fake. I'm cognizant that we've seen several "false dawns" for small caps over the past three years. Each time, the initial momentum faded and large-cap tech reasserted dominance. I think the ISM data and the earnings growth trajectory make this time different from previous attempts, but "this time is different" has been the most expensive phrase in market history, and I hold that possibility with appropriate humility.

Concentration risk within the S&P 600. Financial services represent about 19.7% of the index, with industrials and healthcare also heavily weighted. A sector-specific downturn in regional banking or a broader credit event could drag IJR down even if the small-cap thesis remains intact.

Several near-term events will either strengthen or challenge this thesis:

The delayed January jobs report drops February 11, tomorrow as I write this. A strong report validates the economic expansion narrative. A weak report could spark rate-cut expectations that, paradoxically, might also help small caps.

January CPI data is released February 13. This is the critical data point for the inflation risk scenario. If core CPI comes in above 0.3% month-over-month, expect some volatility in rate-sensitive names.

The Fed chairman transition in May 2026 could reshape monetary policy expectations entirely. President Trump has pressured the Fed to lower rates. A more dovish chair would be a significant tailwind for small caps.

Q1 2026 earnings season in April will be the first real test of whether the 21% earnings growth projections for the S&P 600 are realistic or optimistic. Watch the regional banks and industrial companies that report in mid-April for early signals.

What would change my rating? Two consecutive months of ISM Manufacturing PMI back below 50 would signal that the January expansion was a head fake. Core inflation re-accelerating above 3.0% for multiple months would fundamentally alter the rate outlook. Either scenario would prompt me to downgrade IJR to a Hold.

I rate IJR a Buy at current levels around $48 with a 12-month target of $58-62.

The small-cap rotation is supported by the widest valuation gap in over two decades, accelerating earnings growth that's projected to outpace large caps for the first time this cycle, a manufacturing expansion just confirmed by the ISM's strongest reading since 2022, and a rate environment that directly benefits smaller, more leveraged businesses. IJR gives you that exposure without the 43% dead weight of unprofitable companies that drag on the Russell 2000.

This isn't a trade. It's a position for what I believe will be a multi-quarter, possibly multi-year, rotation that returns market leadership to the broader economy after three years of top-heavy concentration in a handful of tech names.

The Earnout Investor and Jamie Dejter has no stock, option or similar derivative position in any of the companies mentioned, but may initiate a beneficial long position through a purchase of the stock, or the purchase of call options or similar derivatives in IJR over the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it. I have no business relationship with any company whose stock is mentioned in this article.